The urokinase/urokinase receptor system in retinal neovascularization: inhibition by A6 suggests a new therapeutic target.
about
Modulation of CD44 Activity by A6-PeptideIdentification and functional analysis of endothelial tip cell-enriched genesUrokinase and its receptors in chronic kidney disease.Suppression of retinal neovascularization with an antagonist to vascular endothelial cadherin.Role of urokinase inhibitors in choroidal neovascularization.A peptide inhibitor of the urokinase/urokinase receptor system inhibits alteration of the blood-retinal barrier in diabetes.Plasminogen activator inhibitor-1 (PAI-1) facilitates retinal angiogenesis in a model of oxygen-induced retinopathy.Novel targets against retinal angiogenesis in diabetic retinopathy.Opposite modulation of cell migration by distinct subregions of urokinase connecting peptide.uPA-derived peptide, Å6 is involved in the suppression of lipopolysaccaride-promoted inflammatory osteoclastogenesis and the resultant bone loss.Blockade of VEGF-induced GSK/β-catenin signaling, uPAR expression and increased permeability by dominant negative p38α.Inhibition of choroidal neovascularization in rats by the urokinase-derived peptide A6.RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas.Intraocular properties of a repository urokinase receptor antagonist a36 Peptide in rabbits.Endogenous urokinase lacks antifibrotic activity during progressive renal injury
P2860
Q28085166-2AEDC0F0-DDFA-4384-85BF-A19D2D8203B5Q35040504-8475A374-8582-4B56-8B18-FB05AE9E6D43Q35124141-121BF514-2E51-4886-BCBA-FEA1C32E3585Q35606197-E5EB7E68-F465-4751-AB5C-E65722E7899AQ36414191-9D77547D-988A-41B1-9A16-B9842797DD0FQ36841757-92B89F04-7803-415E-8BC1-AEA6CC70E73BQ36935551-0A17956F-1FCD-4B15-852D-64F1E7D6E315Q38013679-DD10B2BB-E516-4E36-A22F-0E28D9EA8D37Q39177238-81D01D6A-929D-4357-9C52-400A04FC7A99Q41506215-C9677113-983E-4D1C-9DE2-634801979090Q41863530-7E0993E4-8901-4454-A578-5C4B35FC582FQ42105130-0062D620-04C2-4BCD-B4D5-152D1ABFABD4Q45878050-2A9F3463-5EFA-4BBD-89B9-0F576C36FBBAQ46377186-73D16F3F-49E9-429B-B20E-A192C4F5E541Q57741348-FD2314A3-8F27-43A5-B8F4-745CB7C2E67A
P2860
The urokinase/urokinase receptor system in retinal neovascularization: inhibition by A6 suggests a new therapeutic target.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
The urokinase/urokinase recept ...... ests a new therapeutic target.
@en
The urokinase/urokinase recept ...... ests a new therapeutic target.
@nl
type
label
The urokinase/urokinase recept ...... ests a new therapeutic target.
@en
The urokinase/urokinase recept ...... ests a new therapeutic target.
@nl
prefLabel
The urokinase/urokinase recept ...... ests a new therapeutic target.
@en
The urokinase/urokinase recept ...... ests a new therapeutic target.
@nl
P2093
P356
P1476
The urokinase/urokinase recept ...... ests a new therapeutic target.
@en
P2093
Erin Warren
Nicholas Talarico
Paul G McGuire
Terence R Jones
P304
P356
10.1167/IOVS.02-1160
P407
P577
2003-06-01T00:00:00Z